[Neuronal and astrocytic plasticity: metabolic aspects]

The brain's function is closely tied to its energy metabolism, which is known to be high relative to other tissues. While whole-brain studies have provided general insights, they lack resolution at the level of individual cell types. This limitation has hindered understanding of how different brain cells manage energy. Recent advances in primary cell culture techniques have enabled more detailed biochemical investigations of specific cell types. Prior research has shown that neurons and glial cells differ in their metabolic profiles, but the mechanisms remain unclear. This gap motivated researchers to explore how neurons and astrocytes handle energy substrates like pyruvate and succinate. The role of enzymes such as lactate dehydrogenase and glutamine synthetase in these differences remains unresolved. No prior work had resolved how hypoxia affects these cells differently. Understanding these metabolic distinctions could clarify brain cell vulnerability to injury.

This study aimed to compare the metabolic activity of neurons and glial cells under controlled conditions. The researchers focused on oxygen consumption and enzyme activity in cultured cells. They wanted to determine whether neurons and astrocytes differ in their energy metabolism. The study also sought to examine how hypoxia impacts these cells. A specific goal was to assess the role of lactate dehydrogenase and its isoenzymatic forms. The researchers also aimed to evaluate the effects of almitrine and raubasine on hypoxia-induced damage. This work addresses a gap in understanding how brain cell types respond to metabolic stress. The findings could help identify which cells are most vulnerable to oxygen deprivation.

The researchers used primary cell cultures of neurons and glial cells. They measured oxygen consumption in the presence of pyruvate or succinate as substrates. Enzyme activities such as hexokinase, malate dehydrogenase, and lactate dehydrogenase were analyzed. The isoenzymatic profile of lactate dehydrogenase was also assessed. Hypoxia was induced to observe changes in enzyme activity and cell viability. Glutamine synthetase activity was measured as an indicator of astrocyte function. The study compared enzyme levels between neurons and glial cells. Almitrine and raubasine were tested for their protective effects under hypoxic conditions.

Neurons consumed more oxygen than glial cells when exposed to pyruvate or succinate. Glial cells showed lower activity in hexokinase, malate dehydrogenase, and glutamate dehydrogenase. In contrast, glial cells exhibited higher lactate dehydrogenase and enolase activity. Neurons displayed a predominance of the aerobic lactate dehydrogenase isoenzymatic form. Under hypoxia, astrocytes showed significant metabolic disruption. Lactate dehydrogenase levels increased, and its isoenzymatic profile changed. Glutamine synthetase activity decreased in hypoxic astrocytes. Almitrine and raubasine partially reversed these hypoxia-induced changes.

The findings suggest that neurons and astrocytes differ in their metabolic profiles. Neurons appear to rely more on aerobic metabolism, while astrocytes may use less aerobic pathways. Hypoxia caused severe disruption in astrocytes, as shown by enzyme activity changes. Almitrine and raubasine may offer some protection against hypoxia-induced damage. The study supports the idea that astrocytes are particularly sensitive to oxygen deprivation. The isoenzymatic profile of lactate dehydrogenase may reflect metabolic state. These results align with the authors’ hypothesis about cell-specific metabolism. Further research is needed to confirm these findings in vivo.